Company intelligence / Profile preview

Piramal

Mumbai, Maharashtra, Indiapiramal.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company has established itself as a global leader in pharmaceutical contract development and manufacturing services with end-to-end capabilities across small molecules, biologics, injectables, HPAPIs and more. It distributes niche differentiated pharma products to over 100 countries. It also provides financial services through its NBFC arm.

Modalities: Small moleculeBiologicInjectable drug productsHigh potency active pharmaceutical ingredients (HPAPI)Vaccine manufacturing support
Industry: Contract Manufacturing Organization

Drug pipeline

2 assets

P7435

IND

Indications: Lipid disorders, Diabetes

1 more asset in the full pipeline.

Request access →

Partnerships

Merck Pharmaceuticals – drug discovery/development dealEli Lilly – drug development partnershipBain Capital Credit – India Resurgence Fund partnershipCPPIB/APG/Ivanhoe Cambridge – investment platforms via financial arm

Beyond the preview

Go deeper on Piramal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piramal.

Explore the full profile